Ginkgo Bioworks CFO Steven P. Coen disposes of $36,045 in common shares
Bitget2026/10/07 21:01Ginkgo Bioworks CFO Steven P. Coen sold 2,403 Class A common shares on Oct. 5, 2026. Sale priced at USD 15 per share. Direct holdings fell to 49,448 shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ginkgo Bioworks Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065349), on October 07, 2026, and is solely responsible for the information contained therein.
- Ginkgo Bioworks CFO Steven P. Coen sold 2,403 Class A common shares on Oct. 5, 2026.
- Sale priced at USD 15 per share.
- Direct holdings fell to 49,448 shares following the transaction.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Crypto prices
More
